The risk of a discontinuation syndrome occurring increases with dosage and length of use.

Collectively known as "antidepressant discontinuation syndrome," these symptoms can be mistaken for a relapse.

Paxil (an antidepressant) and benzodiazepines share this unique phenomenon known as 'discontinuation syndrome'.

For that reason, many doctors describe the effects produced by stopping antidepressants as a "discontinuation syndrome" rather than as withdrawal.

No evidence of discontinuation syndrome was observed in patients switching from 30 mg dapoxetine to placebo.

Still, the symptoms of discontinuation syndrome could be fierce.

Antidepressants in general may produce a discontinuation syndrome.

Another recommendation is to temporarily switch to fluoxetine, which has a longer half-life and thus decreases the severity of discontinuation syndrome.

To avoid the association with dependence, an increasing number of researchers have used a different term, discontinuation syndrome, instead of withdrawal syndrome.

Scientists are not exactly sure why some people develop antidepressant discontinuation syndrome, while others do not.